Molecular Therapy — Oncolytics · 2022 · 47 citations · 52 references
Life SciencesCancer BiologyMolecular BiologyGene ExpressionGenome EditingMolecular OncologyCrispr-based EngineeringCrispr-cas SystemsMicrorna BiologyMicrorna-mediated RegulationRna InterferenceTherapeutic Genome EditingCancer Gene EditingCrispr-based Genome EngineeringCrispr-cas Genome EditingCrispr-cas TherapeuticsCrispr-cas9 Genome EditingMicrorna In CancerMicrorna Regulation In CancerMicrorna Therapeutics
. Overall, we identified miR-21 as a potential target for CRISPR-based therapeutics in glioma.
52
Clonogenic assay of cells in vitro
Nicolaas A.P. Franken, Hans M. Rodermond, Jan Stap et al. · Nature Protocols · 2006 · 4.2K citations
CDC25 Phosphatases as Potential Human Oncogenes
Konstantin Galaktionov, Arthur K. Lee, Jens Eckstein et al. · Science · 1995 · 505 citations
Medicine, Cancer Biology, Oncology +17
RNA-Seq workflow: gene-level exploratory analysis and differential expression
Michael I. Love, Simon Anders, Vladislav Kim et al. · F1000Research · 2015 · 458 citations · Full text